Change search
ReferencesLink to record
Permanent link

Direct link
A novel NGFB point mutation: a phenotype study of heterozygous patients
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Orthopaedics. (Department of Orthopaedics, Gällivare Hospital, Gällivare, Sweden)
Department of Clinical Neuroscience Section of Neurophysiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden .
Department of Internal Medicine, Gällivare Hospital, Gällivare, Sweden.
Department of Clinical Neuroscience Section of Neurophysiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden .
Show others and affiliations
2009 (English)In: Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, E-ISSN 1468-330X, Vol. 80, no 2, 188-195 p.Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: A family with neurological findings similar to hereditary sensory and autonomic neuropathy type V having a point mutation in the nerve growth factor beta (NGFB) gene was recently described. The homozygous genotype gives disabling symptoms. The purpose of the present study was to evaluate the symptoms in heterozygous patients. METHODS: 26 patients heterozygous for the NGFB mutation (12 men, mean age 50 (13-90) years) were examined clinically and answered a health status questionnaire, including the Michigan Neuropathy Screening Instrument (MNSI). 28 relatives (15 men, mean age 44 (15-86) years) without the mutation served as controls in the clinical examination part. 23 of the heterozygotes were examined neurophysiologically and six heterozygous patients underwent a sural nerve biopsy. RESULTS: The heterozygous phenotype ranged from eight patients with Charcot arthropathy starting in adult age and associated with variable symptoms of neuropathy but without complete insensitivity to pain, anhidrosis or mental retardation, to 10 symptom free patients. There was no difference in MNSI between the young heterozygous cases (<55 years old) and the controls. Six of 23 heterozygous patients had impaired cutaneous thermal perception and 11 of 23 had signs of carpal tunnel syndrome. Sural nerve biopsies showed a moderate reduction of both small myelinated (Adelta) and unmyelinated (C) fibres. No apparent correlation of small fibre reduction to symptoms was found. CONCLUSIONS: The NGFB mutation in its heterozygous form results in a milder disease than in homozygotes, with a variable clinical picture, ranging from asymptomatic cases to those with Charcot arthropathy appearing in adult age. Particularly age, but perhaps lifestyle factors also, may influence the development of clinical polyneuropathy.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd , 2009. Vol. 80, no 2, 188-195 p.
National Category
URN: urn:nbn:se:umu:diva-26377DOI: 10.1136/jnnp.2007.136051PubMedID: 18420729OAI: diva2:242281
Available from: 2009-10-07 Created: 2009-10-07 Last updated: 2012-08-09Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Minde, JanSvensson, OlleHolmberg, MonicaToolanen, Göran
By organisation
OrthopaedicsMedical and Clinical Genetics
In the same journal
Journal of Neurology, Neurosurgery and Psychiatry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 60 hits
ReferencesLink to record
Permanent link

Direct link